militari
recruit
high
risk
respiratori
congreg
individu
divers
geograph
locat
semiclos
set
togeth
high
level
close
contact
provid
condit
favor
introduct
transmiss
respiratori
studi
among
militari
recruit
found
high
rate
ill
infect
respiratori
virus
longitudin
studi
singapor
found
militari
personnel
evid
seroconvers
influenza
pandem
compar
individu
commun
hospit
numer
outbreak
respiratori
infect
among
militari
recruit
report
literatur
includ
outbreak
influenza
resumpt
vaccin
adenoviru
type
us
militari
estim
result
decreas
acut
respiratori
shift
predomin
adenoviru
type
type
type
increas
avail
multiplex
molecular
diagnost
assay
yield
data
multipl
pathogen
would
routin
studi
militari
popul
provid
valuabl
inform
regard
epidemiolog
transmiss
respiratori
infect
adult
avail
welldefin
popul
follow
time
despit
data
tropic
set
epidemiolog
influenza
respiratori
infect
differ
substanti
temper
set
limit
increas
understand
etiolog
respiratori
infect
set
import
identifi
opportun
diseas
control
highrisk
militari
popul
identifi
risk
pathogen
emerg
potenti
spread
wider
commun
present
result
longitudin
studi
burden
etiolog
respiratori
infect
thai
militari
recruit
nasal
throat
swab
place
viral
transport
media
store
transfer
arm
forc
research
institut
medic
scienc
test
test
acut
swab
influenza
viru
use
revers
transcript
polymeras
chain
reaction
rtpcr
follow
us
center
diseas
control
also
test
acut
sampl
camp
routin
enrol
followup
specimen
one
camp
use
multiplex
realtim
pcr
assay
compris
bacteri
viral
fungal
target
kit
fast
track
diagnost
eschsuralzett
luxembourg
cycl
threshold
valu
consid
posit
result
previou
studi
shown
high
agreement
commerci
multiplex
assay
specif
viral
sensit
influenza
b
human
coronavirus
high
lower
variabl
viral
target
includ
human
bocaviru
rhinoviru
respiratori
syncyti
viru
human
metapneumoviru
subset
recruit
measur
influenza
antibodi
titer
pair
sera
taken
enrol
end
followup
use
hemagglutinin
inhibit
assay
seroconvers
defin
rise
influenza
subtypespecif
antibodi
titer
individu
consid
risk
date
enter
camp
period
week
comput
rate
uri
ili
number
case
outcom
divid
total
persontim
risk
use
robust
standard
error
calcul
confid
interv
ci
allow
cluster
ill
episod
camp
cohort
determin
percentag
uri
ili
case
posit
target
pathogen
percentag
posit
one
pathogen
percentag
pathogen
identifi
calcul
percentag
recruit
seroconvert
overal
influenza
subtyp
base
rise
antibodi
titer
baselin
end
followup
sampl
determin
percentag
recruit
posit
identif
bacteri
pathogen
recruit
overal
chang
colon
preval
baselin
end
followup
bacteri
speci
risk
acquisit
bacteri
pathogen
followup
period
among
initi
neg
calcul
percentag
uri
ili
case
prescrib
antibiot
investig
clinic
sign
symptom
associ
antibiot
prescript
use
logist
regress
among
prescrib
antibiot
determin
fraction
case
like
viral
etiolog
base
avail
fast
track
multiplex
pcr
result
analys
conduct
use
stata
statacorp
colleg
station
tx
r
studi
approv
institut
review
board
rta
bangkok
thailand
walter
reed
armi
institut
research
london
school
hygien
tropic
medicin
particip
provid
written
inform
consent
total
episod
uri
personweek
followup
yield
overal
uri
rate
per
personweek
upper
respiratori
ill
rate
rang
per
personweek
across
cohort
except
camp
may
cohort
uri
episod
report
figur
ili
episod
give
overal
ili
rate
per
personweek
rang
per
personweek
across
cohort
fever
present
nearli
twothird
uri
episod
cough
sore
throat
occur
uri
episod
nasal
congest
headach
episod
malais
breath
difficulti
episod
symptom
significantli
common
ili
compar
nonili
episod
tabl
influenzalik
ill
case
also
like
take
time
work
nonili
case
versu
p
although
length
time
taken
work
short
median
day
one
hospit
individu
diagnos
pneumonia
work
day
among
uri
ili
sampl
test
multiplex
pcr
pathogen
detect
singl
pathogen
detect
sampl
two
pathogen
three
pathogen
four
pathogen
among
uri
pathogen
common
virus
detect
rhinovirus
influenza
b
coronaviru
adenoviru
influenza
virus
account
uri
case
sampl
test
influenza
rtpcr
fast
track
multiplex
assay
test
posit
least
one
assay
also
posit
rtpcr
rtpcr
posit
four
posit
influenza
one
also
posit
multiplex
assay
remain
posit
influenza
b
rtpcr
also
posit
multiplex
assay
sampl
test
posit
multiplex
assay
neg
rtpcr
among
bacteria
commonli
detect
speci
haemophilu
influenza
type
b
h
influenza
b
streptococcu
pneumonia
klebsiella
pneumonia
howev
commonli
found
combin
pathogen
consid
sampl
singl
organ
found
h
influenza
type
b
found
sampl
h
influenza
b
pneumonia
k
pneumonia
legionella
pneumophila
littl
evid
suggest
etiolog
agent
differ
ili
nonili
case
except
h
influenza
b
coronaviru
occur
frequent
nonili
case
influenza
coronaviru
occur
frequent
ili
case
tabl
analysi
uri
case
time
sinc
start
followup
indic
strong
tempor
cluster
case
cluster
involv
sever
respiratori
pathogen
figur
exampl
singl
cluster
camp
novemb
cohort
result
identif
rhinoviru
coronaviru
well
numer
colon
bacteria
cluster
rhinoviru
also
identifi
combin
parainfluenza
virus
adenoviru
influenza
b
viru
figur
enrol
recruit
report
receiv
influenza
vaccin
previou
month
serolog
subset
rate
influenza
infect
per
personmonth
tabl
thirteen
recruit
seroconvert
train
period
seroconvers
common
influenza
bmassachusett
n
influenza
n
tabl
median
baselin
titer
iqr
influenza
bmassachusett
iqr
influenza
iqr
influenza
iqr
influenza
bbrisban
strong
correl
baselin
end
followup
antibodi
titer
evid
low
prior
exposur
bbrisban
high
prior
exposur
bmassachusett
figur
comparison
overal
seroconvers
clinic
influenza
rate
indic
approxim
influenza
infect
result
clinic
diseas
baselin
recruit
colon
h
influenza
type
b
h
influenza
b
common
colon
bacteria
k
pneumonia
staphylococcu
aureu
pneumonia
end
followup
colon
h
influenza
b
increas
pneumonia
wherea
colon
h
influenza
type
b
k
pneumonia
decreas
respect
addit
moraxella
catarrhali
found
four
l
pneumophila
two
end
followup
sampl
chang
aureu
colon
found
subset
pair
baselin
end
followup
sampl
initi
neg
h
influenza
b
n
risk
h
influenza
b
acquisit
ci
among
neg
pneumonia
baselin
n
risk
acquir
pneumonia
followup
period
ci
uri
episod
prescrib
antibiot
one
prescrib
amoxicillin
azithromycin
multivari
logist
regress
case
like
prescrib
antibiot
present
tonsil
ci
chill
ci
swollen
lymph
node
ci
antibiot
prescript
less
like
patient
present
nasal
congest
ci
differ
prescrib
ili
nonili
patient
uri
case
prescrib
antibiot
avail
multiplex
pcr
result
viral
pathogen
detect
eight
bacteri
target
detect
absenc
pathogen
found
high
incid
uri
thai
armi
recruit
indic
approxim
recruit
experienc
uri
episod
train
period
comparison
militari
cohort
straightforward
differ
set
term
vaccin
polici
season
key
pathogen
influenza
uri
ili
rate
studi
nonetheless
compar
report
studi
unit
despit
found
low
rate
clinic
influenza
minim
vaccin
popul
possibl
reason
could
exposur
circul
influenza
strain
recruit
enter
train
camp
thai
nation
influenza
surveil
data
indic
high
influenza
activ
first
half
influenza
influenza
b
concomitantli
data
indic
recruit
avail
serolog
inform
baselin
influenza
titer
titer
greater
valu
shown
associ
reduct
risk
clinic
influenza
homolog
strain
influenza
b
interest
recruit
also
baselin
titer
influenza
bmassachusett
greater
level
higher
baselin
titer
influenza
bmassachusett
consist
frequent
detect
influenza
b
isol
yamagata
lineag
clinic
specimen
thailand
first
half
studi
fast
track
multiplex
assay
appear
lower
sensit
influenza
compar
cdc
rtpcr
assay
specif
investig
reason
discrep
although
note
two
assay
perform
time
multiplex
assay
perform
end
data
collect
therefor
discount
possibl
sampl
degrad
might
influenc
rel
perform
fast
track
assay
although
influenza
incid
low
pathogen
detect
sensit
multiplex
diagnost
indic
high
frequenc
respiratori
pathogen
cocircul
multipl
virus
includ
rhinoviru
adenoviru
coronavirus
well
influenza
addit
found
high
level
colon
numer
bacteri
speci
includ
type
b
b
h
influenza
k
pneumonia
pneumonia
although
specif
studi
transmiss
chain
epidemiolog
link
case
ill
context
studi
recruit
leav
camp
train
period
occurr
respiratori
pathogen
like
result
transmiss
within
camp
rather
extern
sourc
intens
transmiss
bacteri
speci
appar
risk
acquir
h
influenza
b
pneumonia
among
initi
noncolon
individu
respect
bacteri
speci
also
commonli
found
sampl
uri
case
colon
natur
bacteri
speci
make
difficult
determin
clinic
relev
detect
howev
h
influenza
type
b
b
identifi
clinic
sampl
absenc
pathogen
suggest
pathogen
could
respons
ill
fraction
adult
uri
case
interestingli
h
influenza
type
b
previous
associ
signific
burden
uri
possibl
howev
case
caus
pathogen
includ
multiplex
assay
high
level
colon
bacteri
speci
also
point
need
judici
use
antibiot
treat
uri
militari
popul
quarter
uri
case
studi
prescrib
broadspectrum
antibiot
like
infect
caus
viral
pathogen
base
multiplex
pcr
result
although
lack
addit
inform
determin
whether
result
advers
antibiot
resist
pattern
high
level
antibiot
use
popul
high
background
bacteri
colon
present
risk
develop
antibiot
resist
highlight
import
improv
rapid
diagnost
rule
viral
etiolog
aid
clinic
manag
addit
point
need
increas
antibiot
stewardship
healthcar
provid
educ
reduc
unnecessari
use
antibiot
militari
set
studi
also
emphas
import
systemat
microbiolog
surveil
uri
militari
popul
allow
prompt
detect
control
outbreak
earli
identif
emerg
pathogen
may
circul
could
introduc
wider
popul
particularli
import
infect
control
option
close
set
limit
vaccin
coverag
key
pathogen
low
limit
resourc
meant
possibl
conduct
multiplex
diagnost
baselin
acut
end
followup
sampl
well
influenza
serolog
result
limit
power
investig
whether
colon
influenc
risk
ill
factor
associ
colon
acquisit
bacteria
addit
cocircul
multipl
pathogen
make
difficult
establish
chain
transmiss
would
requir
detail
microbi
sequenc
inform
clinic
sign
symptom
avail
present
inform
regard
durat
individu
symptom
addit
clinic
investig
conduct
longitudin
cours
ill
routin
perform
specif
barrack
set
popul
characterist
limit
generaliz
find
militari
set
similar
condit
nevertheless
studi
provid
key
data
regard
epidemiolog
transmiss
respiratori
pathogen
militari
popul
tropic
set
result
emphas
need
improv
infect
prevent
control
strategi
militari
set
given
potenti
intens
transmiss
wide
rang
respiratori
pathogen
